Clinical Trial

Non-Invasive Preeclampsia Screening and Biobank

Name: Non-Invasive Preeclampsia Screening and Biobank — clinical trial record (NCT06643741)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.

Protocol Amendment History 2 changes

notable Primary completion pushed: 2026-06-01 -> 2027-06-01 2026-07-21

minor Completion pushed: 2026-07-01 -> 2027-07-01 2026-07-21

Trial Details

NCT Number	NCT06643741
Lead Sponsor	Sequenom, Inc. Collaborators: Rutgers Robert Wood Johnson Medical School, Laboratory Corporation of America
Conditions	Preeclampsia (PE)
Enrollment	6,550 participants
Start Date	2025-02-02
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-20